{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:46:29Z","timestamp":1792464389170,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ellagic acid (Ea) is an example of a bioactive polyphenolic compound with numerous beneficial effects; therefore, it is used to counteract adrenaline toxicity in this study. Thirty-six male rats were categorized into 6 groups of 6 rats. Group (1) was given oral purified distilled water for thirty successive days and injected with a saline for the next two days. Groups (2) and (3) received 7.5 and 15 mg\/kg body weight Ea orally, followed by saline injection for two days. Group (4) was given distilled water orally for 30 uninterrupted days, followed by adrenaline injections for the next two days. Groups (5) and (6) received 7.5 and 15 mg\/kg Ea for 30 days, followed by adrenaline injections for the next two days. Electrocardiogram (ECG) changes, oxidative stress, inflammation, immunohistochemistry, and histopathological alterations were evaluated. Specific biomarkers associated with kidney, liver, and heart injuries were recorded. At the higher dose, the Ea counteracted adrenaline-induced heart rate decrease, prolongation of the QT interval, and elevation of the ST interval in rats. It also enhanced kidney, liver, and heart function, ameliorating abnormal ECG patterns and tissue architecture changes. Ea suppressed PI3K\/AKT signaling pathway and promoted nuclear factor erythroid 2-related factor 2 (NRF2) expression in the heart, possibly due to its antioxidative and anti-inflammation potential. Additionally, the study suggested a mechanistic aspect regarding the Ea\u2019s antioxidant activity through modulating the Keap1-NRF2 axis based on a validated computational approach that warrants further investigation. This study highlights the potential benefits of Ea in reducing heart injury.<\/jats:p>","DOI":"10.1038\/s41598-025-21317-7","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:45:28Z","timestamp":1760957128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ellagic acid mediates cardioprotection against adrenaline-induced toxicity via PI3K\/AKT and Keap1-NRF2 axes"],"prefix":"10.1038","volume":"15","author":[{"given":"Tahany Saleh","family":"Aldayel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar A. Abou","family":"Haleka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala M.","family":"Ebaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M. Abd","family":"EL-Fadeal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Abdelrazek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba N.","family":"Gad EL-Hak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan M.","family":"Rashwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"3\u20134","key":"21317_CR1","first-page":"116","volume":"42","author":"JA Yagiela","year":"1995","unstructured":"Yagiela, J. A. Vasoconstrictor agents for local anesthesia. Anesth. Prog. 42 (3\u20134), 116\u2013120 (1995).","journal-title":"Anesth. Prog."},{"issue":"15","key":"21317_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199210083271503","volume":"327","author":"CG Brown","year":"1992","unstructured":"Brown, C. G. et al. A comparison of Standard-Dose and High-Dose epinephrine in cardiac arrest outside the hospital. N. Engl. J. Med. 327 (15), 1051\u20131055 (1992).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"21317_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0885066609340519","volume":"24","author":"MW D\u00fcnser","year":"2009","unstructured":"D\u00fcnser, M. W. & Hasibeder, W. R. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J. J. Intensive Care Med. 24 (5), 293\u2013316 (2009).","journal-title":"J. J. Intensive Care Med."},{"issue":"4","key":"21317_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ccep.2017.07.004","volume":"9","author":"AL Wit","year":"2017","unstructured":"Wit, A. L. Basic electrophysiologic mechanisms of sudden cardiac death caused by acute myocardial ischemia and infarction. J. Cardiac Electrophysiol. Clin. 9 (4), 525\u2013536 (2017).","journal-title":"J. Cardiac Electrophysiol. Clin."},{"issue":"17","key":"21317_CR5","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa032440","volume":"350","author":"MBM Perondi","year":"2004","unstructured":"Perondi, M. B. M., Reis, A. G., Paiva, E. F., Nadkarni, V. M. & Berg, R. A. A comparison of high-dose and standard-dose epinephrine in children with cardiac arrest. N. Engl. J. Med. 350 (17), 1722\u20131730 (2004).","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"21317_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJM199210083271502","volume":"327","author":"IG Stiell","year":"1992","unstructured":"Stiell, I. G. et al. High-dose epinephrine in adult cardiac arrest. N. Engl. J. Med. 327 (15), 1045\u20131050 (1992).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"21317_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40001-022-00974-8","volume":"28","author":"H Zhong","year":"2023","unstructured":"Zhong, H. et al. Therapeutic and adverse effects of adrenaline on patients who suffer out-of-hospital cardiac arrest: a systematic review and meta-analysis. Eur. J. Med. Res. 28 (1), 24 (2023).","journal-title":"Eur. J. Med. Res."},{"issue":"7","key":"21317_CR8","first-page":"843","volume":"26","author":"C Ezeani","year":"2023","unstructured":"Ezeani, C., Beshel, J. A., Okon, I. A., Inyang, E. G. & Owu, D. U. Vitamin C modulates adrenaline-augmented gastric injury via cardiac troponin\/creatine kinase pathway in Wistar rats. Iran. J. Basic. Med. Sci. 26 (7), 843 (2023).","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"21317_CR9","doi-asserted-by":"crossref","unstructured":"Kadambadi, N., Webber, M. & Captur, G. Electrocardiographic imaging: technical developments and future applications for non-invasive electroanatomical study of the human heart. J. Heart (2025).","DOI":"10.1136\/heartjnl-2024-324963"},{"issue":"23","key":"21317_CR10","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.3390\/molecules28237813","volume":"28","author":"Z Liu","year":"2023","unstructured":"Liu, Z., Chen, Y., Mei, Y., Yan, M. & Liang, H. Gasdermin D-mediated pyroptosis in diabetic cardiomyopathy: molecular mechanisms and Pharmacological implications. J. Molecules. 28 (23), 7813 (2023).","journal-title":"J. Molecules"},{"issue":"Suppl 2","key":"21317_CR11","doi-asserted-by":"publisher","first-page":"P478","DOI":"10.1186\/cc6699","volume":"12","author":"W De Corte","year":"2008","unstructured":"De Corte, W. et al. Serum Urea as a marker for initiation of renal replacement therapy in ICU patients with acute kidney injury. J. Crit. Care. 12 (Suppl 2), P478 (2008).","journal-title":"J. Crit. Care"},{"issue":"3","key":"21317_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/antiox10030414","volume":"10","author":"A Menzel","year":"2021","unstructured":"Menzel, A. et al. Common and novel markers for measuring inflammation and oxidative stress ex vivo in research and clinical practice\u2014which to use regarding disease outcomes? J. Antioxid. 10 (3), 414 (2021).","journal-title":"J. Antioxid."},{"issue":"6","key":"21317_CR13","doi-asserted-by":"publisher","first-page":"e23739","DOI":"10.1002\/jbt.23739","volume":"38","author":"A Goyal","year":"2024","unstructured":"Goyal, A. et al. Unveiling myricetin\u2019s Pharmacological potency: A comprehensive exploration of the molecular pathways with special focus on PI3K\/AKT and Nrf2 signaling. J. J. Biochem. Mol. Toxicol. 38 (6), e23739 (2024).","journal-title":"J. J. Biochem. Mol. Toxicol."},{"key":"21317_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.saa.2014.04.052","volume":"130","author":"I Kilic","year":"2014","unstructured":"Kilic, I., Ye\u015filo\u011flu, Y. & Bayrak, Y. Spectroscopic studies on the antioxidant activity of ellagic acid. J. Spectrochimica Acta Part. A: Mol. Biomol. Spectrosc. 130, 447\u2013452 (2014).","journal-title":"J. Spectrochimica Acta Part. A: Mol. Biomol. Spectrosc."},{"issue":"3","key":"21317_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1745-4514.2005.00031.x","volume":"29","author":"D Vattem","year":"2005","unstructured":"Vattem, D. & Shetty, K. Biological functionality of ellagic acid: a review. J. J. Food Biochem. 29 (3), 234\u2013266 (2005).","journal-title":"J. J. Food Biochem."},{"issue":"1","key":"21317_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.phrs.2012.10.018","volume":"68","author":"M Qui\u00f1ones","year":"2013","unstructured":"Qui\u00f1ones, M., Miguel, M. & Aleixandre, A. Beneficial effects of polyphenols on cardiovascular disease. J. Pharmacol. Res. 68 (1), 125\u2013131 (2013).","journal-title":"J. Pharmacol. Res."},{"key":"21317_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-444-64181-6.00006-1","volume":"60","author":"JM Lorenzo","year":"2019","unstructured":"Lorenzo, J. M. et al. Sources, chemistry, and biological potential of ellagitannins and ellagic acid derivatives. J. Stud. Nat. Prod. Chem. 60, 189\u2013221 (2019).","journal-title":"J. Stud. Nat. Prod. Chem."},{"issue":"2","key":"21317_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/1871525713666150123152711","volume":"12","author":"S Haidarali","year":"2014","unstructured":"Haidarali, S. et al. Targeting apoptotic pathways in myocardial infarction: attenuated by phytochemicals. J. Cardiovasc. Hematol. Agents Med. Chem. 12 (2), 72\u201385 (2014).","journal-title":"J. Cardiovasc. Hematol. Agents Med. Chem."},{"issue":"5","key":"21317_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/nu9050523","volume":"9","author":"R Mattera","year":"2017","unstructured":"Mattera, R. et al. Effects of polyphenols on oxidative stress-mediated injury in cardiomyocytes. J. Nutrients. 9 (5), 523 (2017).","journal-title":"J. Nutrients"},{"issue":"1","key":"21317_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.metabol.2012.06.003","volume":"62","author":"MM Kannan","year":"2013","unstructured":"Kannan, M. M. & Quine, S. D. Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats. J. Metabolism. 62 (1), 52\u201361 (2013).","journal-title":"J. Metabolism"},{"issue":"14","key":"21317_CR21","first-page":"1191","volume":"11","author":"S Lecour","year":"2011","unstructured":"Lecour, S. & Lamont, K. Natural polyphenols and cardioprotection. J. Mini Reviews Med. Chem. 11 (14), 1191\u20131199 (2011).","journal-title":"J. Mini Reviews Med. Chem."},{"issue":"7","key":"21317_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/15384101.2022.2161959","volume":"22","author":"AH Ajzashokouhi","year":"2023","unstructured":"Ajzashokouhi, A. H., Rezaee, R., Omidkhoda, N. & Karimi, G. Natural compounds regulate the PI3K\/Akt\/GSK3\u03b2 pathway in myocardial ischemia-reperfusion injury. J. Cell. Cycle. 22 (7), 741\u2013757 (2023).","journal-title":"J. Cell. Cycle"},{"issue":"6","key":"21317_CR23","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1080\/10408398.2022.2118226","volume":"64","author":"S Fakhri","year":"2024","unstructured":"Fakhri, S. et al. Modulation of integrin receptor by polyphenols: downstream Nrf2-Keap1\/ARE and associated cross-talk mediators in cardiovascular diseases. J. Crit. Reviews Food Sci. Nutr. 64 (6), 1592\u20131616 (2024).","journal-title":"J. Crit. Reviews Food Sci. Nutr."},{"issue":"10","key":"21317_CR24","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.3390\/app10103353","volume":"10","author":"G Zuccari","year":"2020","unstructured":"Zuccari, G. et al. Formulation strategies to improve oral bioavailability of ellagic acid. J. Appl. Sci. 10 (10), 3353 (2020).","journal-title":"J. Appl. Sci."},{"issue":"1","key":"21317_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s43994-024-00153-x","volume":"11","author":"IZ Sadiq","year":"2025","unstructured":"Sadiq, I. Z., Usman, A., Muhammad, A. & Ahmad, K. H. Sample size calculation in biomedical, clinical and biological sciences research. J. J. Umm Al-Qura Univ. Appl. Sci. 11 (1), 133\u2013141 (2025).","journal-title":"J. J. Umm Al-Qura Univ. Appl. Sci."},{"issue":"1","key":"21317_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.metabol.2012.06.003","volume":"62","author":"MM Kannan","year":"2013","unstructured":"Kannan, M. M. & Quine, S. D. Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats. Metabolism 62 (1), 52\u201361 (2013).","journal-title":"Metabolism"},{"issue":"4","key":"21317_CR27","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/ijms22041668","volume":"22","author":"RS Najjar","year":"2021","unstructured":"Najjar, R. S. & Feresin, R. G. Protective role of polyphenols in heart failure: molecular targets and cellular mechanisms underlying their therapeutic potential. J. Int. J. Mol. Sci. 22 (4), 1668 (2021).","journal-title":"J. Int. J. Mol. Sci."},{"key":"21317_CR28","first-page":"100028","volume":"3","author":"SAA Haleka","year":"2024","unstructured":"Haleka, S. A. A., Rashwan, H. M., Ebaid, H. M., Abdelrazek, H. M. A. & Gad El Hak, H. N. Methanolic extract of cleome Droserifolia mitigates epinephrine-induced cardiac injury. Pharmacol. Res. - Nat. Prod. 3, 100028 (2024).","journal-title":"Pharmacol. Res. - Nat. Prod."},{"key":"21317_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00210-020-01957-4","volume":"394","author":"ME Youssef","year":"2021","unstructured":"Youssef, M. E., Abdelrazek, H. M. & Moustafa, Y. M. Cardioprotective role of GTS-21 by attenuating the TLR4\/NF-\u03baB pathway in streptozotocin-induced diabetic cardiomyopathy in rats. Naunyn. Schmiedebergs Arch. Pharmacol. 394, 11\u201331 (2021).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"21317_CR30","doi-asserted-by":"publisher","first-page":"131655","DOI":"10.1016\/j.foodchem.2021.131655","volume":"375","author":"R Zhang","year":"2022","unstructured":"Zhang, R. et al. Safety assessment of crude saponins from Chenopodium Quinoa willd. Husks: 90-day oral toxicity and gut microbiota & metabonomics study in rats. Food Chem. 375, 131655 (2022).","journal-title":"Food Chem."},{"issue":"5","key":"21317_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/nu14051025","volume":"14","author":"HN Gad El-Hak","year":"2022","unstructured":"Gad El-Hak, H. N. et al. Methanolic Phoenix dactylifera L. extract ameliorates cisplatin-induced hepatic injury in male rats. Nutrients 14 (5), 1025 (2022).","journal-title":"Nutrients"},{"key":"21317_CR32","unstructured":"Altamimi, J. et al. Ellagic acid protects against diabetic cardiomyopathy in rats by stimulating cardiac silent information regulator 1 signaling. J. Physiol. Pharmacol. 71(10) (2020)."},{"issue":"3","key":"21317_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2165\/00003088-197904030-00003","volume":"4","author":"TD Bjornsson","year":"1979","unstructured":"Bjornsson, T. D. Use of serum creatinine concentrations to determine renal function1. Clin. Pharmacokinet. 4 (3), 200\u2013222 (1979).","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"21317_CR34","first-page":"11","volume":"9","author":"S Shrestha","year":"2008","unstructured":"Shrestha, S., Gyawali, P., Shrestha, R., Poudel, B. & Sigdel, M. Serum Urea and creatinine in diabetic and non-diabetic subjects. J. Nepal. Association Med. Lab. Sci. P. 9 (1), 11\u201312 (2008).","journal-title":"J. Nepal. Association Med. Lab. Sci. P"},{"key":"21317_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00604-008-0044-z","volume":"164","author":"Y Zhao","year":"2009","unstructured":"Zhao, Y., Yang, X., Lu, W., Liao, H. & Liao, F. Uricase based methods for determination of uric acid in serum. Microchim. Acta. 164, 1\u20136 (2009).","journal-title":"Microchim. Acta"},{"issue":"4","key":"21317_CR36","first-page":"271","volume":"85","author":"S Ahn","year":"2021","unstructured":"Ahn, S. et al. Comparison of clinical and inflammatory parameters in dogs with pyometra before and after ovariohysterectomy. J. Can. J. Veterinary Res. 85 (4), 271\u2013278 (2021).","journal-title":"J. Can. J. Veterinary Res."},{"issue":"2","key":"21317_CR37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/hep.22657","volume":"49","author":"RZ Yang","year":"2009","unstructured":"Yang, R. Z. et al. Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity. Hepatology 49 (2), 598\u2013607 (2009).","journal-title":"Hepatology"},{"issue":"3","key":"21317_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0016-5085(72)80154-9","volume":"62","author":"MM Kaplan","year":"1972","unstructured":"Kaplan, M. M. Alkaline phosphatase. Gastroenterology 62 (3), 452\u2013468 (1972).","journal-title":"Gastroenterology"},{"key":"21317_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-8977-6-1","volume":"6","author":"B Guo","year":"2009","unstructured":"Guo, B., Zebda, R., Drake, S. J. & Sayes, C. M. Synergistic effect of co-exposure to carbon black and Fe 2 O 3 nanoparticles on oxidative stress in cultured lung epithelial cells. J. Part. Fibre Toxicol. 6, 1\u201313 (2009).","journal-title":"J. Part. Fibre Toxicol."},{"key":"21317_CR40","first-page":"189","volume":"2","author":"JD Artiss","year":"1997","unstructured":"Artiss, J. D. & Zak, B. Measurement of cholesterol concentration. Handb. Lipoprotein Test. 2, 189\u2013205 (1997).","journal-title":"Handb. Lipoprotein Test."},{"issue":"6","key":"21317_CR41","first-page":"1137","volume":"55","author":"A Czerny Ba, Pawlik","year":"2003","unstructured":"Czerny Ba, Pawlik, A., Juzyszyn, Z. & Mysliwiec, Z. Effect of Tamoxifen on bone mineral density and blood lipids in ovariectomized rats. Pol. J. Pharmacol. 55 (6), 1137\u20131142 (2003).","journal-title":"Pol. J. Pharmacol."},{"issue":"1","key":"21317_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-10-6","volume":"10","author":"L Savale","year":"2009","unstructured":"Savale, L. et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir. Res. 10 (1), 1\u201313 (2009).","journal-title":"Respir. Res."},{"key":"21317_CR43","doi-asserted-by":"publisher","first-page":"109816","DOI":"10.1016\/j.intimp.2023.109816","volume":"116","author":"AC Famurewa","year":"2023","unstructured":"Famurewa, A. C., Asogwa, N. T. & Ezea, S. C. Antidiabetic drug sitagliptin blocks cyclophosphamide cerebral neurotoxicity by activating Nrf2 and suppressing redox cycle imbalance, inflammatory iNOS\/NO\/NF-\u03baB response and caspase-3\/Bax activation in rats. Int. Immunopharmacol. 116, 109816 (2023).","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"21317_CR44","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3390\/antiox10121908","volume":"10","author":"E Hassler","year":"2021","unstructured":"Hassler, E. et al. Sex-Specific association of serum anti-oxidative capacity and leukocyte telomere length. Antioxidants 10 (12), 1908 (2021).","journal-title":"Antioxidants"},{"issue":"1","key":"21317_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.sjbs.2020.09.036","volume":"28","author":"NA AlFaris","year":"2021","unstructured":"AlFaris, N. A. et al. The protective effect of shrimp cooked in different methods on high-cholesterol-induced fatty liver in rats. Saudi J. Biol. Sci. 28 (1), 170\u2013182 (2021).","journal-title":"Saudi J. Biol. Sci."},{"key":"21317_CR46","doi-asserted-by":"publisher","first-page":"117168","DOI":"10.1016\/j.lfs.2019.117168","volume":"241","author":"NI El-Naseery","year":"2020","unstructured":"El-Naseery, N. I., Mousa, H. S., Noreldin, A. E., Ali, H. & Elewa, Y. H. Aging-associated Immunosenescence via alterations in Splenic immune cell populations in rat. Life Sci. 241, 117168 (2020).","journal-title":"Life Sci."},{"issue":"3","key":"21317_CR47","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.3390\/ijms14036106","volume":"14","author":"EH Jansen","year":"2013","unstructured":"Jansen, E. H. & Ruskovska, T. Comparative analysis of serum (anti) oxidative status parameters in healthy persons. Int. J. Mol. Sci. 14 (3), 6106\u20136115 (2013).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"21317_CR48","first-page":"97","volume":"10","author":"O Palabiyik","year":"2019","unstructured":"Palabiyik, O. et al. Alteration in cardiac PI3K\/Akt\/mTOR and ERK signaling pathways with the use of growth hormone and swimming, and the roles of miR21 and miR133. Biomed. Rep. 10 (2), 97\u2013106 (2019).","journal-title":"Biomed. Rep."},{"issue":"5","key":"21317_CR49","doi-asserted-by":"publisher","first-page":"pdbprot4986","DOI":"10.1101\/pdb.prot4986","volume":"2008","author":"AH Fischer","year":"2008","unstructured":"Fischer, A. H., Jacobson, K. A., Rose, J. & Zeller, R. Hematoxylin and Eosin staining of tissue and cell sections. Cold Spring Harbor Protoc. 2008 (5), pdbprot4986 (2008).","journal-title":"Cold Spring Harbor Protoc."},{"issue":"1","key":"21317_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carpath.2007.07.011","volume":"18","author":"BJ Smith","year":"2009","unstructured":"Smith, B. J. et al. Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. J. Cardiovasc. Pathol. 18 (1), 1\u201310 (2009).","journal-title":"J. Cardiovasc. Pathol."},{"issue":"1","key":"21317_CR51","doi-asserted-by":"publisher","first-page":"104414","DOI":"10.1016\/j.arabjc.2022.104414","volume":"16","author":"N Diniyah","year":"2023","unstructured":"Diniyah, N. et al. In Silico and Docking studies on the binding activities of Keap1 of antioxidant compounds in non-oilseed legumes. Arab. J. Chem. 16 (1), 104414 (2023).","journal-title":"Arab. J. Chem."},{"issue":"6","key":"21317_CR52","doi-asserted-by":"publisher","first-page":"e07317","DOI":"10.1016\/j.heliyon.2021.e07317","volume":"7","author":"TI Adelusi","year":"2021","unstructured":"Adelusi, T. I., Abdul-Hammed, M., Idris, M. O., Oyedele, Q. K. & Adedotun, I. O. Molecular dynamics, quantum mechanics and Docking studies of some Keap1 inhibitors - An insight into the atomistic mechanisms of their antioxidant potential. Heliyon 7 (6), e07317 (2021).","journal-title":"Heliyon"},{"issue":"1","key":"21317_CR53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/med.21925","volume":"43","author":"E Crisman","year":"2023","unstructured":"Crisman, E. et al. KEAP1\u2010NRF2 protein\u2013protein interaction inhibitors: Design, Pharmacological properties and therapeutic potential. J. Med. Res. Reviews. 43 (1), 237\u2013287 (2023).","journal-title":"J. Med. Res. Reviews"},{"issue":"8","key":"21317_CR54","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: new Docking Methods, expanded force Field, and python bindings. J. Chem. Inf. Model. 61 (8), 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"21317_CR55","doi-asserted-by":"publisher","first-page":"113323","DOI":"10.1016\/j.ecoenv.2022.113323","volume":"233","author":"Q Xue","year":"2022","unstructured":"Xue, Q. et al. Evaluation of the binding performance of flavonoids to Estrogen receptor alpha by Autodock, Autodock Vina and Surflex-Dock. Ecotoxicol. Environ. Saf. 233, 113323 (2022).","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"21","key":"21317_CR56","doi-asserted-by":"publisher","first-page":"15949","DOI":"10.1021\/acs.jmedchem.1c01351","volume":"64","author":"D Norton","year":"2021","unstructured":"Norton, D. et al. Fragment-Guided discovery of pyrazole carboxylic acid inhibitors of the Kelch-like ECH-Associated protein 1: nuclear factor erythroid 2 related factor 2 (KEAP1:NRF2) protein-Protein interaction. J. Med. Chem. 64 (21), 15949\u201315972 (2021).","journal-title":"J. Med. Chem."},{"issue":"7","key":"21317_CR57","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-12-4400","volume":"73","author":"BE Hast","year":"2013","unstructured":"Hast, B. E. et al. Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination. Cancer Res. 73 (7), 2199\u20132210 (2013).","journal-title":"Cancer Res."},{"issue":"21","key":"21317_CR58","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1128\/MCB.00753-07","volume":"27","author":"KI Tong","year":"2007","unstructured":"Tong, K. I. et al. Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell. Biol. 27 (21), 7511\u20137521 (2007).","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"21317_CR59","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1021\/acs.jmedchem.9b00279","volume":"62","author":"TD Heightman","year":"2019","unstructured":"Heightman, T. D. et al. Structure-Activity and Structure-Conformation relationships of Aryl propionic acid inhibitors of the Kelch-like ECH-Associated protein 1\/Nuclear factor erythroid 2-Related factor 2 (KEAP1\/NRF2) protein-Protein interaction. J. Med. Chem. 62 (9), 4683\u20134702 (2019).","journal-title":"J. Med. Chem."},{"issue":"8","key":"21317_CR60","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","volume":"59","author":"TG Davies","year":"2016","unstructured":"Davies, T. G. et al. Monoacidic inhibitors of the Kelch-like ECH-Associated protein 1: nuclear factor erythroid 2-Related factor 2 (KEAP1:NRF2) protein-Protein interaction with high cell potency identified by Fragment-Based discovery. J. Med. Chem. 59 (8), 3991\u20134006 (2016).","journal-title":"J. Med. Chem."},{"issue":"3","key":"21317_CR61","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1021\/jm0302997","volume":"47","author":"M Kontoyianni","year":"2004","unstructured":"Kontoyianni, M., McClellan, L. M. & Sokol, G. S. Evaluation of Docking performance: comparative data on Docking algorithms. J. Med. Chem. 47 (3), 558\u2013565 (2004).","journal-title":"J. Med. Chem."},{"key":"21317_CR62","doi-asserted-by":"publisher","first-page":"105510","DOI":"10.1016\/j.ejps.2020.105510","volume":"154","author":"SO Albuquerque","year":"2020","unstructured":"Albuquerque, S. O. et al. Biological evaluation and molecular modeling of peptidomimetic compounds as inhibitors for O-GlcNAc transferase (OGT). Eur. J. Pharm. Sciences: Official J. Eur. Federation Pharm. Sci. 154, 105510 (2020).","journal-title":"Eur. J. Pharm. Sciences: Official J. Eur. Federation Pharm. Sci."},{"issue":"9","key":"21317_CR63","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.bmcl.2019.02.031","volume":"29","author":"AS de Souza","year":"2019","unstructured":"de Souza, A. S. et al. 3-Acyltetramic acids as a novel class of inhibitors for human Kallikreins 5 and 7. Bioorg. Med. Chem. Lett. 29 (9), 1094\u20131098 (2019).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"21317_CR64","doi-asserted-by":"publisher","first-page":"105770","DOI":"10.1016\/j.bioorg.2022.105770","volume":"123","author":"AM El-Naggar","year":"2022","unstructured":"El-Naggar, A. M., Hassan, A. M. A., Elkaeed, E. B., Alesawy, M. S. & Al-Karmalawy, A. A. Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2. Bioorg. Chem. 123, 105770 (2022).","journal-title":"Bioorg. Chem."},{"key":"21317_CR65","doi-asserted-by":"crossref","unstructured":"Elhady, S. S. et al. Molecular Docking and dynamics simulation study of hyrtios erectus isolated scalarane sesterterpenes as potential SARS-CoV-2 dual target inhibitors. Biology 10(5) (2021).","DOI":"10.3390\/biology10050389"},{"issue":"11","key":"21317_CR66","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.2174\/1871520619666190417153350","volume":"19","author":"M Maher","year":"2019","unstructured":"Maher, M., Kassab, A. E., Zaher, A. F. & Mahmoud, Z. Novel Pyrazolo[3,4-d]pyrimidines as potential cytotoxic agents: Design, Synthesis, molecular Docking and CDK2 Inhibition. Anti-cancer Agents Med. Chem. 19 (11), 1368\u20131381 (2019).","journal-title":"Anti-cancer Agents Med. Chem."},{"key":"21317_CR67","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00706-012-0856-8","volume":"144","author":"A Simi","year":"2013","unstructured":"Simi, A. et al. Study of ellagic acid electro-oxidation mechanism. Monatshefte Chem. 144, 121\u2013128 (2013).","journal-title":"Monatshefte Chem."},{"key":"21317_CR68","doi-asserted-by":"crossref","unstructured":"Meram, S., Falcon, T. & Paxton, J. H. Special Populations: Cardiac Arrest. In Emergent Vascular Access: A Guide for Healthcare Professionals, 199\u2013215 (2021).","DOI":"10.1007\/978-3-030-77177-5_9"},{"key":"21317_CR69","doi-asserted-by":"publisher","first-page":"111724","DOI":"10.1016\/j.ejmech.2019.111724","volume":"183","author":"S Alfei","year":"2019","unstructured":"Alfei, S. et al. Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review. J. Eur. J. Med. Chem. 183, 111724 (2019).","journal-title":"J. Eur. J. Med. Chem."},{"issue":"4","key":"21317_CR70","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/ptr.6565","volume":"34","author":"V Baradaran Rahimi","year":"2020","unstructured":"Baradaran Rahimi, V., Ghadiri, M., Ramezani, M. & Askari, V. R. Antiinflammatory and anti-cancer activities of pomegranate and its constituent, ellagic acid: evidence from cellular, animal, and clinical studies. J. Phytotherapy Res. 34 (4), 685\u2013720 (2020).","journal-title":"J. Phytotherapy Res."},{"issue":"4","key":"21317_CR71","doi-asserted-by":"publisher","first-page":"E819","DOI":"10.1152\/ajpendo.00145.2003","volume":"285","author":"C Meyer","year":"2003","unstructured":"Meyer, C. et al. Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans. Am. J. Physiology-Endocrinology Metabolism. 285 (4), E819\u2013E26 (2003).","journal-title":"Am. J. Physiology-Endocrinology Metabolism"},{"issue":"1","key":"21317_CR72","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.exger.2011.10.002","volume":"47","author":"MR Castro","year":"2012","unstructured":"Castro, M. R. et al. Aging increases mitochondrial DNA damage and oxidative stress in liver of rhesus monkeys. Exp. Gerontol. 47 (1), 29\u201337 (2012).","journal-title":"Exp. Gerontol."},{"issue":"4","key":"21317_CR73","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1053\/euhj.1999.1748","volume":"21","author":"I Menown","year":"2000","unstructured":"Menown, I., Mackenzie, G. & Adgey, A. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur. Heart J. 21 (4), 275\u2013283 (2000).","journal-title":"Eur. Heart J."},{"key":"21317_CR74","doi-asserted-by":"crossref","unstructured":"El-Marasy, S. A., El Awdan, S. A., Hassan, A. & Abdallah, H. M. Cardioprotective effect of thymol against adrenaline-induced myocardial injury in rats. Heliyon 6(7) (2020).","DOI":"10.1016\/j.heliyon.2020.e04431"},{"issue":"8","key":"21317_CR75","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.jacc.2006.01.051","volume":"47","author":"H Skulstad","year":"2006","unstructured":"Skulstad, H. et al. Grading of myocardial dysfunction by tissue doppler echocardiography: a comparison between velocity, displacement, and strain imaging in acute ischemia. J. Am. Coll. Cardiol. 47 (8), 1672\u20131682 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"21317_CR76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jflm.2014.09.011","volume":"28","author":"PS Ghormade","year":"2014","unstructured":"Ghormade, P. S., Kumar, N. B., Tingne, C. V. & Keoliya, A. N. Distribution & diagnostic efficacy of cardiac markers CK-MB & LDH in pericardial fluid for postmortem diagnosis of ischemic heart disease. J. Forensic Leg. Med. 28, 42\u201346 (2014).","journal-title":"J. Forensic Leg. Med."},{"issue":"1","key":"21317_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1388-9842(00)00085-4","volume":"3","author":"F Muders","year":"2001","unstructured":"Muders, F. et al. Alterations in myocardial creatinine kinase (CK) and lactate dehydrogenase (LDH) isoenzyme-distribution in a model of left ventricular dysfunction. Eur. J. Heart Fail. 3 (1), 1\u20135 (2001).","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"21317_CR78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejphar.2011.02.037","volume":"659","author":"MM Kannan","year":"2011","unstructured":"Kannan, M. M. & Quine, S. D. Ellagic acid ameliorates isoproterenol induced oxidative stress: evidence from electrocardiological, biochemical and histological study. Eur. J. Pharmacol. 659 (1), 45\u201352 (2011).","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"21317_CR79","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4314\/ahs.v15i1.18","volume":"15","author":"IC Maduka","year":"2015","unstructured":"Maduka, I. C., Neboh, E. E. & Ufelle, S. A. The relationship between serum cortisol, adrenaline, blood glucose and lipid profile of undergraduate students under examination stress. Afr. Health Sci. 15 (1), 131\u2013136 (2015).","journal-title":"Afr. Health Sci."},{"issue":"4","key":"21317_CR80","doi-asserted-by":"publisher","first-page":"180","DOI":"10.31989\/ffhd.v10i4.702","volume":"10","author":"Y Shiojima","year":"2020","unstructured":"Shiojima, Y., Takahashi, M., Kikuchi, M. & Akanuma, M. Effect of ellagic acid on body fat and triglyceride reduction in healthy overweight volunteers: A randomized, double-blind, placebo-controlled parallel group study. J. Funct. Foods Health Disease. 10 (4), 180\u2013194 (2020).","journal-title":"J. Funct. Foods Health Disease"},{"issue":"2","key":"21317_CR81","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00394-012-0358-9","volume":"52","author":"SK Panchal","year":"2013","unstructured":"Panchal, S. K., Ward, L. & Brown, L. Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Eur. J. Nutr. 52 (2), 559\u2013568 (2013).","journal-title":"Eur. J. Nutr."},{"key":"21317_CR82","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.toxrep.2021.04.008","volume":"8","author":"A Salama","year":"2021","unstructured":"Salama, A., Mansour, D. & Hegazy, R. The cardio and renoprotective role of ginseng against epinephrine-induced myocardial infarction in rats: involvement of angiotensin II type 1 receptor\/protein kinase C. Toxicol. Rep. 8, 908\u2013919 (2021).","journal-title":"Toxicol. Rep."},{"issue":"2","key":"21317_CR83","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/ki.1992.45","volume":"41","author":"ZY Quan","year":"1992","unstructured":"Quan, Z. Y., Walser, M. & Hill, G. S. Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level. Kidney Int. 41 (2), 326\u2013333 (1992).","journal-title":"Kidney Int."},{"issue":"4","key":"21317_CR84","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.1097\/CCM.0b013e318169167f","volume":"36","author":"R Bellomo","year":"2008","unstructured":"Bellomo, R., Wan, L. & May, C. Vasoactive drugs and acute kidney injury. Crit. Care Med. 36 (4), S179\u2013S86 (2008).","journal-title":"Crit. Care Med."},{"issue":"3","key":"21317_CR85","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/mnfr.200900087","volume":"54","author":"M Chao Cy","year":"2010","unstructured":"Chao Cy, M., Mc, C., Kc, Y. & Mc Anti-glycative and anti\u2010inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. J. Mol. Nutr. Food Res. 54 (3), 388\u2013395 (2010).","journal-title":"J. Mol. Nutr. Food Res."},{"issue":"2","key":"21317_CR86","first-page":"1","volume":"6","author":"RA Abdullah","year":"2015","unstructured":"Abdullah, R. A., Jarjees, M. T. T. & Al-Youzbaki, W. B. Effect of stress dose of epinephrine on the histology of liver in male mice. Pharm. Glob. 6(2), 1 (2015).","journal-title":"Pharm. Glob."},{"key":"21317_CR87","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.pharep.2018.02.007","volume":"70","author":"S Mehrzadi","year":"2018","unstructured":"Mehrzadi, S. et al. Ellagic acid mitigates sodium arsenite-induced renal and hepatic toxicity in male Wistar rats. J. Pharmacol. Rep. 70, 712\u2013719 (2018).","journal-title":"J. Pharmacol. Rep."},{"issue":"5","key":"21317_CR88","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1742-7843.2007.00129.x","volume":"101","author":"A Y\u00fcce","year":"2007","unstructured":"Y\u00fcce, A., Ate\u015f\u015fahin, A., \u00c7eriba\u015f\u0131, A. O. & Aksakal, M. Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. J. Basic. Clin. Pharmacol. 101 (5), 345\u2013349 (2007).","journal-title":"J. Basic. Clin. Pharmacol."},{"key":"21317_CR89","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","volume":"34","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Activation of Nrf2\/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J. J. Adv. Res. 34, 43\u201363 (2021).","journal-title":"J. J. Adv. Res."},{"issue":"8","key":"21317_CR90","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2174\/1381612043452901","volume":"10","author":"X-L Chen","year":"2004","unstructured":"Chen, X-L. & Kunsch, C. Induction of cytoprotective genes through Nrf2\/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. J. Curr. Pharm. Des. 10 (8), 879\u2013891 (2004).","journal-title":"J. Curr. Pharm. Des."},{"issue":"1","key":"21317_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1359-6101(98)00024-0","volume":"10","author":"A Meager","year":"1999","unstructured":"Meager, A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev. 10 (1), 27\u201339 (1999).","journal-title":"Cytokine Growth Factor Rev."},{"issue":"21","key":"21317_CR92","doi-asserted-by":"publisher","first-page":"16023","DOI":"10.1074\/jbc.275.21.16023","volume":"275","author":"T Ishii","year":"2000","unstructured":"Ishii, T. et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275 (21), 16023\u201316029 (2000).","journal-title":"J. Biol. Chem."},{"key":"21317_CR93","doi-asserted-by":"publisher","first-page":"851257","DOI":"10.3389\/fnagi.2022.851257","volume":"14","author":"T Jiang","year":"2022","unstructured":"Jiang, T. & He, Y. Recent advances in the role of nuclear factor Erythroid-2-Related factor 2 in spinal cord injury: regulatory mechanisms and therapeutic options. Front. Aging Neurosci. 14, 851257 (2022).","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"21317_CR94","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2009.07.024","volume":"244","author":"HY Cho","year":"2010","unstructured":"Cho, H. Y. & Kleeberger, S. R. Nrf2 protects against airway disorders. Toxicol. Appl. Pharmacol. 244 (1), 43\u201356 (2010).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"21317_CR95","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/ars.2008.2242","volume":"11","author":"MJ Calkins","year":"2009","unstructured":"Calkins, M. J. et al. The Nrf2\/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signal. 11 (3), 497\u2013508 (2009).","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"21317_CR96","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","volume":"236","author":"K Itoh","year":"1997","unstructured":"Itoh, K. et al. An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (2), 313\u2013322 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"21317_CR97","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1073\/pnas.0307301101","volume":"101","author":"N Wakabayashi","year":"2004","unstructured":"Wakabayashi, N. et al. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U S A. 101 (7), 2040\u20132045 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"21317_CR98","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pneurobio.2012.09.003","volume":"100","author":"M Zhang","year":"2013","unstructured":"Zhang, M. et al. Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog Neurobiol. 100, 30\u201347 (2013).","journal-title":"Prog Neurobiol."},{"issue":"24","key":"21317_CR99","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","volume":"24","author":"DD Zhang","year":"2004","unstructured":"Zhang, D. D., Lo, S. C., Cross, J. V., Templeton, D. J. & Hannink, M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24 (24), 10941\u201310953 (2004).","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"21317_CR100","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00204-011-0674-5","volume":"85","author":"L Baird","year":"2011","unstructured":"Baird, L. & Dinkova-Kostova, A. T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 85 (4), 241\u2013272 (2011).","journal-title":"Arch. Toxicol."},{"issue":"7","key":"21317_CR101","doi-asserted-by":"publisher","first-page":"10074","DOI":"10.3390\/molecules190710074","volume":"19","author":"YS Keum","year":"2014","unstructured":"Keum, Y. S. & Choi, B. Y. Molecular and chemical regulation of the Keap1-Nrf2 signaling pathway. Molecules 19 (7), 10074\u201310089 (2014).","journal-title":"Molecules"},{"issue":"14","key":"21317_CR102","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2174\/1381612824666180327165604","volume":"24","author":"YT Yeung","year":"2018","unstructured":"Yeung, Y. T., Aziz, F., Guerrero-Castilla, A. & Arguelles, S. Signaling pathways in inflammation and anti-inflammatory therapies. Curr. Pharm. Design. 24 (14), 1449\u20131484 (2018).","journal-title":"Curr. Pharm. Design"},{"issue":"4","key":"21317_CR103","doi-asserted-by":"publisher","first-page":"a022145","DOI":"10.1101\/cshperspect.a022145","volume":"9","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Alexander, P. B. & Wang, X-F. TGF-\u03b2 family signaling in the control of cell proliferation and survival. Cold Spring Harb. Perspect. Biol. 9 (4), a022145 (2017).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"21317_CR104","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12672-025-02471-w","volume":"16","author":"N Hedayati","year":"2025","unstructured":"Hedayati, N. et al. Modulation of the PI3K\/Akt signaling pathway by Resveratrol in cancer: molecular mechanisms and therapeutic opportunity. J. Discover Oncol. 16 (1), 669 (2025).","journal-title":"J. Discover Oncol."},{"issue":"2","key":"21317_CR105","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/dna.2014.2630","volume":"34","author":"B-P Huang","year":"2015","unstructured":"Huang, B-P. et al. AMPK activation inhibits expression of Proinflammatory mediators through downregulation of PI3K\/p38 MAPK and NF-\u03baB signaling in murine macrophages. DNA Cell Biol. 34 (2), 133\u2013141 (2015).","journal-title":"DNA Cell Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21317-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21317-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21317-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T23:02:21Z","timestamp":1761346941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21317-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21317"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21317-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal study protocol was approved by the Faculty of Science, Suez Canal University, Ismailia, Egypt (approval number: REC348\/2024) for studies involving animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"36489"}}